Pretorius M - Search Results

1

Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.

Gamboa JL, Pretorius M, Todd-Tzanetos DR, Luther JM, Yu C, Ikizler TA, Brown NJ. Gamboa JL, et al. Among authors: pretorius m. J Am Soc Nephrol. 2012 Feb;23(2):334-42. doi: 10.1681/ASN.2011030287. Epub 2011 Dec 8. J Am Soc Nephrol. 2012. PMID: 22158433 Free PMC article. Clinical Trial.

2

Smoking impairs bradykinin-stimulated t-PA release.

Pretorius M, Rosenbaum DA, Lefebvre J, Vaughan DE, Brown NJ. Pretorius M, et al. Hypertension. 2002 Mar 1;39(3):767-71. doi: 10.1161/hy0302.105767. Hypertension. 2002. PMID: 11897760 Clinical Trial.

3

Ethnicity affects vasodilation, but not endothelial tissue plasminogen activator release, in response to bradykinin.

Rosenbaum DA, Pretorius M, Gainer JV, Byrne D, Murphey LJ, Painter CA, Vaughan DE, Brown NJ. Rosenbaum DA, et al. Among authors: pretorius m. Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):1023-8. doi: 10.1161/01.atv.0000017704.45007.1d. Arterioscler Thromb Vasc Biol. 2002. PMID: 12067915

4

Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.

Pretorius M, Rosenbaum D, Vaughan DE, Brown NJ. Pretorius M, et al. Circulation. 2003 Feb 4;107(4):579-85. doi: 10.1161/01.cir.0000046268.59922.a4. Circulation. 2003. PMID: 12566370 Clinical Trial.

5

Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass.

Pretorius M, Murphey LJ, McFarlane JA, Vaughan DE, Brown NJ. Pretorius M, et al. Circulation. 2003 Dec 23;108(25):3079-83. doi: 10.1161/01.CIR.0000105765.54573.60. Epub 2003 Dec 1. Circulation. 2003. PMID: 14656921 Clinical Trial.

6

Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function.

Summar ML, Gainer JV, Pretorius M, Malave H, Harris S, Hall LD, Weisberg A, Vaughan DE, Christman BW, Brown NJ. Summar ML, et al. Among authors: pretorius m. Hypertension. 2004 Feb;43(2):186-91. doi: 10.1161/01.HYP.0000112424.06921.52. Epub 2004 Jan 12. Hypertension. 2004. PMID: 14718356

7

Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass.

Pretorius M, McFarlane JA, Vaughan DE, Brown NJ, Murphey LJ. Pretorius M, et al. Clin Pharmacol Ther. 2004 Oct;76(4):379-87. doi: 10.1016/j.clpt.2004.06.004. Clin Pharmacol Ther. 2004. PMID: 15470338 Clinical Trial.

8

Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men.

Pretorius M, Luther JM, Murphey LJ, Vaughan DE, Brown NJ. Pretorius M, et al. Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2435-40. doi: 10.1161/01.ATV.0000186185.13977.94. Epub 2005 Sep 15. Arterioscler Thromb Vasc Biol. 2005. PMID: 16166566 Clinical Trial.

9

A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.

Pretorius M, Scholl FG, McFarlane JA, Murphey LJ, Brown NJ. Pretorius M, et al. Clin Pharmacol Ther. 2005 Nov;78(5):477-85. doi: 10.1016/j.clpt.2005.08.010. Clin Pharmacol Ther. 2005. PMID: 16321614 Clinical Trial.

10

Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans.

Murphey LJ, Malave HA, Petro J, Biaggioni I, Byrne DW, Vaughan DE, Luther JM, Pretorius M, Brown NJ. Murphey LJ, et al. Among authors: pretorius m. J Pharmacol Exp Ther. 2006 Sep;318(3):1287-92. doi: 10.1124/jpet.106.104026. Epub 2006 Jun 13. J Pharmacol Exp Ther. 2006. PMID: 16772538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters